Reaction
Blastic Plasmacytoid Dendritic Cell Neoplasia reporting signals
As of the last recalculation, Blastic Plasmacytoid Dendritic Cell Neoplasia appears in 78 FAERS reports alongside 3 co-occurring drug terms. The strongest observed disproportionality signal is AZACITIDINE (PRR 210.2).
Important: FAERS is a spontaneous, voluntary, unverified reporting system. PRR and ROR identify reporting patterns for investigation; they are not incidence rates and do not establish causation.
| Drug | Co-reports | PRR | ROR |
|---|---|---|---|
| Azacitidine | 18 | 210.2 | 210.3 |
| Azacitidine For | 10 | 168.1 | 168.2 |
| Venetoclax | 21 | 124.2 | 124.2 |